Congenital Diseases Associated with Central Nervous System Flashcards

1
Q

Explain the steps of morphogenesis

A
  • Fusing of neural folds
  • fusing starts between hindbrain and spinal cord and progresses up and down
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the possible deformities of neural tube closure

A
  • Anencephaly (more cranial)
  • Cranioarchischisis
  • Spina bifida (more caudal)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where are the closure points in mouse

A

Closure 1 - Between the hindbrain and spinal cord
Closure 2 - On top of the head
Closure 3 - Near the face

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where are the closure points in human

A

Closure 1 - Between the hindbrain and spinal cord
Closure 2 - On top of the head
Closure 3 - Near the face
Closure 4 - Just above number 1
Closure 5 - Most caudal end

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 2 modes of neural tube closure

A
  • Primary neurulation:
    rolling-up of tube
    closure is by fold apposition then “zipping-up”
    Finally, at cranial and caudal neuropores
  • Secondary neurulation:
    tunnelling or hollowing of tail bud

The primary and secondary neural tube become continuous
Somites 30-31 in human (2nd sacral)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the steps in primary neuralation

A

Shaping of the neural plate occurs by convergence/extension

Tubing requires bending at hinge points

Cell wedging at hinge points: microtubules & actin filaments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the process of convergence-extension

A

A process of lengthening by narrowing, which requires cells to become polarized, in the plane of the cell layer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the Wnt-PCP pathway

A

It is a network of proteins that lead to changes in the transcriptional state of the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the steps in the Wnt-PCP signalling pathway

A

Wnts: secreted signalling molecules – the ligand

Frizzleds: Wnt receptor, transmembrane proteins

Vangl and Celsr: co-receptors necessary for signal transduction

Dvl1-3: cytoplasmic proteins, activated upon interaction between Wnts and Fzds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What mutations in the Ant-PCP pathway can lead to neural tube defects

A

Mouse mutants in components of the Wnt-PCP pathway show neural tube defects:

celsr1-/- (crash)
vangl-/- (loop-tail)
scribble-/- (circletail)
dvl1/2
fzd3/6

The neural plate is abnormally broad with a non-bending region between neural folds - leading to chraniorachischisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe how cell wedging and apical constriction occurs

A

Actin myosin filament in the cell contract at the apical portion contracting the cell to a bottle shape.
The cytoskeleton is polarised and the actin-myosin filament the maintain the shape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how does mutation lead to lack of neural tube closure

A

celsr1-/- (crash)
vangl-/- (loop-tail)
scribble-/- (circletail)
dvl1/2
fzd3/6
- these messengers mediate the constriction an when mutated it doesn’t take place
- therefore neural tube closure doesn’t occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the Environmental factors associated with NTDs

A
  • Maternal diet
    Vitamin deficiency/malnutrition
    Folate
    Inositol
    High levels of sugar
  • Maternal obesity
  • Diabetes
  • Hypertermia
  • Teratogenic agents
    Valproic acid (VPA)
  • Alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is folic acid important in NTDs

A
  • Clinical trials in humans in the 90’s showed a preventive effect of maternal folic acid supplementation prior to and during pregnancy
    4mg folate; >5x  recurrence risk; better with preconception start
  • Supplementation dose:
    Current practice: 0.4 mg/day general; 5 mg/day recurrence
    …but supplementation does not reach everyone
  • Fortification better than supplementation?
    e.g. mandatory cereal grain fortification in USA
    Fortification: ~ 70 - 200ug/day (USA, Canada)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the uses of Folic acid

A
  • Nucleotide synthesis
  • Serine-glycine interconversion
  • Mitochondrial tRNA modification
  • Methyl group biogenesis
    proliferation
    respiration
    epigenetic modifications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the mutations associated with folic acid

A

Mutations in folate related genes associated to NTDs:

  • Transport molecules such as FOLR1, SLC46A1
  • Metabolising enzymes such as MTHFD1, GLDC
17
Q

Why may folate deficiency not be the sole reason for NTDs

A

Usually there is a predisposing mutation
These can be in genes involved in folate transport/metabolism
But also in other unrelated genes important for NT closure
Examples: pax3, ciliogenesis genes
Folate mechanism of action in these cases is unclear

18
Q

What is Inositol and what is its functions

A
  • Essential building block of phosphoinositides - structural components of the plasma membrane
  • Involved in glucose metabolism and modulation of insulin levels
19
Q

How can Inositol prevent NTDs in folate-resistant experimental models

A

Spina bifida frequency in curly tail mouse mutants is reduced by inositol supplementation

Clinical trials still insufficient evidence for a protective effect in humans

20
Q

Can other factors cause NTDs

A

Environmental factors or nutrients deficiency can lead to NTDs in genetically predisposed animals